<DOC>
	<DOCNO>NCT00864721</DOCNO>
	<brief_summary>The purpose research study find effect ( good bad ) sunitinib patient NSCLC .</brief_summary>
	<brief_title>Sunitinib Non Small Cell Lung Cancer Patients Over 70</brief_title>
	<detailed_description>In trial , activity tolerability sunitinib malate ( Sutent ) examine previously untreated elderly patient ( &gt; 70 year old ) felt candidate standard cytotoxic chemotherapy .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Has measurable , metastatic NSCLC , elderly NSCLC patient 70 year age felt candidate standard chemotherapy discretion treat physician may also enrol long meet criterion ; `` special consideration '' patient enrollment study must approve Dr. Reynolds DR. Smith Dr. Reynolds absence . Patients must nonsquamous histology eligible study . Has receive prior chemotherapy current disease . Has ECOG Performance status . Is 70 year age older.Has resolution acute toxic effect radiotherapy surgical procedure NCI CTCAE . If fertile , patient ( male ) agree acceptable method birthcontrol avoid pregnancy duration study period 2 month thereafter . Has sign recent Patient Informed Consent Form . Has sign Pate int Authorization Form . Has predominantly squamous NSCLC histology . Had prior treatment study drug drug . Has history hypersensitivity component study drug . Has evidence antecedent hemoptysis , squamous histology , ongoing anticoagulation clot diathesis . Preexisting hemoptysis Grade 2 , cavitating lesion clear proximity involvement blood vessel . Has major surgery radiation therapy within 4 week start study treatment . Has NCI CTCAE ( Version 3.0 ) Grade 34 hemorrhage within 4 week start study treatment . Has history know spinal cord compression , carcinomatous meningitis , evidence symptomatic brain leptomeningeal disease screen CT MRI scan ; however , treat , stable , asymptomatic brain metastasis allow . Has follow within 6 month prior study drug administration : myocardial infarction , severe/unstable angina , coronary/peripheral artery bypass graft , symptomatic congestive heart failure , cerebrovascular accident transient ischemic attack , pulmonary embolism . Has ongoing cardiac dysrhythmias NCI CTCAE ( Version 3.0 ) Grade 2 . Has prolong QTc interval baseline EKG . Has uncontrolled hypertension . Has preexist thyroid abnormality thyroid function maintain normal range medication . Is receive concurrent treatment another clinical trial . Supportive care trial nontreatment trial , ( eg , QOL ) , allow . Is receive concurrent immunotherapy , hormonal therapy , radiation therapy . Is receive concurrent investigational therapy receive therapy within past 30 day . Has serious uncontrolled intercurrent medical psychiatric illness , include serious infection . Has history malignancy within last 5 year ( except cure basal cell carcinoma skin carcinoma situ uterine cervix ) , could affect diagnosis assessment study drug . Is unable comply requirement study</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Untreated NSCLC patient &gt; 70</keyword>
</DOC>